Induction Healthcare Group PLC Block listing Interim Review
29 Enero 2024 - 1:00AM
RNS Regulatory News
RNS Number : 0590B
Induction Healthcare Group PLC
29 January 2024
Induction Healthcare Group
PLC
("Induction", the "Company", or the
"Group")
Block Listing Six Monthly
Return
Induction Healthcare (AIM: INHC), a leading digital health platform driving transformation of
healthcare systems worldwide, makes
the following six monthly update on its block listing pursuant to
AIM Rule 29 and Schedule 6 of the AIM Rules for
Companies:
|
Name of applicant:
|
Induction Healthcare Group
PLC
LEI: 213800RY96GCZQW5TP19
|
|
Name of scheme:
|
The Induction Healthcare NTA Share
Option Plan
|
|
Period of return:
|
From:
|
27/07/2023
|
To:
|
27/01/2024
|
|
Number and class of securities
originally admitted and the date of admission
|
3,500,000 ordinary shares on 26 July
2021
|
|
Balance of unallotted securities
under scheme(s) from initial application:
|
3,500,000
|
|
Plus: The
amount by which the block scheme(s) has been increased since the
date of the last return (if any increase has been applied
for):
|
nil
|
|
Less: Number
of securities issued/allotted under scheme(s) during the
period:
|
1,469,075
|
|
Equals: Balance under scheme(s) not yet issued/allotted at end of
period:
|
1,701,352
|
|
Contact:
|
Louise Torr, Company
Secretary
louise.t@inductionhealthcare.com
|
|
|
|
|
|
|
|
|
|
|
|
| |
ENQUIRIES
|
Induction Healthcare Group
Christopher Samler, Chair
Paul Tambeau, Chief Executive Officer
|
+44 (0)7712 194092
+44 (0)7983 104443
|
|
|
|
|
|
|
Singer Capital Markets (Nominated Adviser and
Broker)
|
+44 (0)20 7496 3000
|
|
|
Philip Davies
|
|
|
About Induction -
www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a
suite of software solutions through a single integrated platform
that transforms care delivery. Our system-wide applications
help healthcare providers and administrators to deliver care at any
stage remotely as well as face-to-face - giving the communities
they serve greater flexibility, control and ease of access.
Purpose-built for integration with leading Electronic Medical
Record (EMR) platforms, our products offer immediate stand-alone
value that becomes even greater when integrated with pre-existing
systems.
Used at scale by national and
regional healthcare systems, as well non-health government
services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital
in the British Isles.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
BLRPPUCGGUPCURQ
Induction Healthcare (LSE:INHC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Induction Healthcare (LSE:INHC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
